ClinicalTrials.gov
public full text
Public Domain
The Individualized M(X) Drug-resistant TB Treatment Strategy Study
This is a randomized controlled clinical trial comparing treatment success of a gene-derived individualized drug-resistant Tuberculosis regimen to a standard Tuberculosis regimen based on South African National Tuberculosis guidelines.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluating Newly Approved Drugs for Multidrug-resistant TB#980001
- WHO operational handbook on tuberculosis: module 2: screening: systematic screening for tuberculosis disease#223731
- Lifetime burden of disease due to incident tuberculosis : a global reappraisal including post-tuberculosis sequelae#470000
- WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment: web annex B: conflict of interest assessment for experts contributing to the handbook content#223727
- Economic Evaluation of New MDR TB Regimens#463735
Record · ID 800597
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive